A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Intermediate Uveitis, Posterior Uveitis

In brief

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.

Key facts

Study ID

NCT00333814

Run by

Allergan

People needed

229

Starts

2006-05-01

Expected to finish

2009-04-01

Last updated by the study team

2011-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older with a diagnosis of chronic intermediate uveitis in at least one eye

You may not qualify if…

• Uncontrolled systemic disease
• Any active ocular infections

Where it is running

• Study site — Dallas, Texas, United States
• Study site — Sydney, Australia
• Study site — Vienna, Austria
• Study site — São Paulo, São Paulo/SP, Brazil
• Study site — Montreal, Quebec, Canada
• Study site — Prague, Czechia
• Study site — Paris, France
• Study site — Heidelberg, Germany
• Study site — Cholargós, Greece
• Study site — Hyderabad, India
• Study site — Petah Tikva, Israel
• Study site — Gdansk, Poland
• Study site — Coimbra, Portugal
• Study site — Johannesburg, South Africa
• Study site — Seoul, South Korea
• Study site — Madrid, Spain
• Study site — Lausanne, Switzerland
• Study site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.